These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 4391348)

  • 1. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activity of various neuroleptics after single repeated treatment in the mice submitted to the four plate test and the escape test].
    Gouret C; Raynaud G
    C R Seances Soc Biol Fil; 1974; 168(2-3):270-5. PubMed ID: 4156656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arousal inhibiting and catalepsy in neuroleptic drugs].
    Stille G
    Arzneimittelforschung; 1966 Feb; 16(2):255-6. PubMed ID: 6013811
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release.
    Frisk-Holmberg M; van der Kleijn E
    Eur J Pharmacol; 1972 May; 18(2):139-47. PubMed ID: 4113999
    [No Abstract]   [Full Text] [Related]  

  • 6. Some relationships concerning the chemical structure, hemolytic activity, and therapeutic potency of phenothiazines.
    Mao TS; Noval JJ
    Biochem Pharmacol; 1966 Apr; 15(4):501-4. PubMed ID: 6005981
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. 3. Inhibition kinetics with highly purified D-amino acid oxidase.
    Gabay S; Harris SR
    Biochem Pharmacol; 1967 May; 16(5):803-12. PubMed ID: 4382519
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
    Nielsen IM
    Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenothiazine depression of approach and avoidance behavior.
    Ray OS; Bivens LW
    Psychopharmacologia; 1967; 10(3):196-203. PubMed ID: 5626645
    [No Abstract]   [Full Text] [Related]  

  • 10. Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.
    Snyder S; Greenberg D; Yamamura HI
    Arch Gen Psychiatry; 1974 Jul; 31(1):58-61. PubMed ID: 4152054
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):161-74. PubMed ID: 5364169
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of various neuroleptic drugs on noise escape response in rats.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 18(3):249-59. PubMed ID: 5530581
    [No Abstract]   [Full Text] [Related]  

  • 13. The prediction of sedative potency of neuroleptics.
    Loew DM
    Mod Probl Pharmacopsychiatry; 1970; 5():47-50. PubMed ID: 5527167
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
    Lal S; Sourkes TL
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):289-301. PubMed ID: 4672248
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phenamine antagonism as a treat for experimental evaluation of neuroleptics].
    Raevskiĭ KS
    Farmakol Toksikol; 1973; 36(2):149-54. PubMed ID: 4151668
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of neuroleptic agents in the chronic pharmacological experiment].
    Stille G; Lauener H
    Arzneimittelforschung; 1974 Sep; 24(9):1292-4. PubMed ID: 4479794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of 15 neuroleptics (butyrophenones and phenothiazines) on changes in noradrenaline content of the brain and activity of the rat in the self stimulation test].
    Dresse A
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):353-65. PubMed ID: 5916740
    [No Abstract]   [Full Text] [Related]  

  • 18. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
    BOHACEK N; HAJNSEK F; SARTORIUS N
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of the antiavoidance effects of various agents by anticholinergic drugs.
    Hanson HM; Stone CA; Witoslawski JJ
    J Pharmacol Exp Ther; 1970 May; 173(1):117-24. PubMed ID: 4986082
    [No Abstract]   [Full Text] [Related]  

  • 20. [TRIAL SYSTEMATIZATION OF NEUROLEPTIC COMBINATIONS].
    LAMBERT PA
    Encephale; 1964; 53():SUPPL:262-75. PubMed ID: 14161540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.